nitrates has been researched along with Primary Peritonitis in 23 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Arginine deficiency and chronic inflammation may cause immune dysfunction." | 7.78 | Appropriate dose of parenteral arginine enhances immunity of peripheral blood cells and splenocytes in rats with subacute peritonitis. ( Chen, YH; Hsiao, CC; Hsu, LS; Lee, CH; Lo, HC, 2012) |
| "Chronic inflammation accompanied by arginine deficiency, immune dysfunction, and excess nitric oxide (NO) production is a clinical condition found in patients with peritonitis." | 7.78 | The dose-dependent immunoregulatory effects of the nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester in rats with sub-acute peritonitis. ( Hsiao, CC; Lee, CH; Lo, HC; Tsao, LY, 2012) |
| "To investigate the effects of glutamine (GLN)-enriched diets before and GLN-containing total parenteral nutrition (TPN) after sepsis or both on the secretion of cytokines and their mRNA expression levels in splenocytes of rats with septic peritonitis." | 7.73 | Effects of glutamine supplementation on splenocyte cytokine mRNA expression in rats with septic peritonitis. ( Chen, WJ; Chiu, WC; Lai, YN; Lin, MT; Shang, HF; Yeh, SL, 2005) |
| "Peritonitis was induced by a single injection of zymosan A or zymosan supplemented with morphine in Swiss mice." | 5.38 | Toll-like receptors expression and NF-κB activation in peritoneal leukocytes in morphine-mediated impairment of zymosan-induced peritonitis in swiss mice. ( Kołaczkowska, E; Mazur, AI; Natorska, J; Wypasek, E, 2012) |
| "Arginine deficiency and chronic inflammation may cause immune dysfunction." | 3.78 | Appropriate dose of parenteral arginine enhances immunity of peripheral blood cells and splenocytes in rats with subacute peritonitis. ( Chen, YH; Hsiao, CC; Hsu, LS; Lee, CH; Lo, HC, 2012) |
| "Chronic inflammation accompanied by arginine deficiency, immune dysfunction, and excess nitric oxide (NO) production is a clinical condition found in patients with peritonitis." | 3.78 | The dose-dependent immunoregulatory effects of the nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester in rats with sub-acute peritonitis. ( Hsiao, CC; Lee, CH; Lo, HC; Tsao, LY, 2012) |
| "To investigate the effects of glutamine (GLN)-enriched diets before and GLN-containing total parenteral nutrition (TPN) after sepsis or both on the secretion of cytokines and their mRNA expression levels in splenocytes of rats with septic peritonitis." | 3.73 | Effects of glutamine supplementation on splenocyte cytokine mRNA expression in rats with septic peritonitis. ( Chen, WJ; Chiu, WC; Lai, YN; Lin, MT; Shang, HF; Yeh, SL, 2005) |
| " Thus, the objective of this study was to assess the role of iNOS in modulating neutrophil (PMN) extravasation in an oyster glycogen-induced model of acute peritonitis in rats." | 3.70 | Role of inducible nitric oxide synthase in leukocyte extravasation in vivo. ( Cockrell, A; Gray, L; Grisham, MB; Jourd'heuil, D; Kawachi, S; Laroux, FS; Van der Heyde, H, 1999) |
| " In vivo treatment with ip administration of 3-aminobenzamide (10 mg/kg, 1 and 6 hrs after zymosan injection) or nicotinamide (50 mg/kg, 1 and 6 hrs after zymosan injection) significantly decreased mortality, inhibited the development of peritonitis, and reduced peroxynitrite formation." | 3.70 | Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat. ( Caputi, AP; Costantino, G; Cuzzocrea, S; Sottile, A; Teti, D; Zingarelli, B, 1999) |
| "Peritonitis was induced by a single injection of zymosan A or zymosan supplemented with morphine in Swiss mice." | 1.38 | Toll-like receptors expression and NF-κB activation in peritoneal leukocytes in morphine-mediated impairment of zymosan-induced peritonitis in swiss mice. ( Kołaczkowska, E; Mazur, AI; Natorska, J; Wypasek, E, 2012) |
| "MODS was induced by zymosan administration (500 mg/kg, suspended in saline solution, i." | 1.35 | Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome. ( Bramanti, P; Caminiti, R; Cuzzocrea, S; Di Paola, R; Esposito, E; Genovese, T; Malleo, G; Mazzon, E, 2008) |
| "Although sepsis is the major cause of mortality and morbidity in the critically ill, precise mechanism(s) causing multiorgan dysfunction remain unclear." | 1.32 | Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. ( Brealey, D; Jacques, TS; Karyampudi, S; Novelli, M; Singer, M; Smolenski, RT; Stidwill, R; Taylor, V, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (52.17) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 7 (30.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boccella, S | 1 |
| Panza, E | 1 |
| Lista, L | 1 |
| Belardo, C | 1 |
| Ianaro, A | 1 |
| De Rosa, M | 1 |
| de Novellis, V | 1 |
| Pavone, V | 1 |
| Amoruso, A | 1 |
| Fresu, LG | 1 |
| Dalli, J | 1 |
| Miglietta, D | 1 |
| Bardelli, C | 1 |
| Federici Canova, D | 1 |
| Perretti, M | 1 |
| Brunelleschi, S | 1 |
| Lo, HC | 3 |
| Hung, CY | 1 |
| Huang, FH | 1 |
| Su, TC | 1 |
| Lee, CH | 3 |
| Ji, M | 1 |
| Li, R | 1 |
| Li, GM | 1 |
| Fan, Y | 1 |
| Dong, L | 1 |
| Yang, J | 1 |
| Peng, YG | 1 |
| Wu, J | 1 |
| Chen, YH | 1 |
| Hsu, LS | 1 |
| Hsiao, CC | 2 |
| Tsao, LY | 1 |
| Wypasek, E | 1 |
| Natorska, J | 1 |
| Mazur, AI | 1 |
| Kołaczkowska, E | 1 |
| Brealey, D | 1 |
| Karyampudi, S | 1 |
| Jacques, TS | 1 |
| Novelli, M | 1 |
| Stidwill, R | 1 |
| Taylor, V | 1 |
| Smolenski, RT | 1 |
| Singer, M | 1 |
| Yeh, SL | 1 |
| Lai, YN | 1 |
| Shang, HF | 1 |
| Lin, MT | 1 |
| Chiu, WC | 1 |
| Chen, WJ | 1 |
| Kikuchi, M | 1 |
| Endo, S | 1 |
| Inada, K | 1 |
| Inoue, Y | 1 |
| Wakabayashi, G | 1 |
| Ishikura, H | 1 |
| Tanaka, T | 1 |
| Malleo, G | 1 |
| Mazzon, E | 4 |
| Genovese, T | 1 |
| Di Paola, R | 1 |
| Caminiti, R | 1 |
| Esposito, E | 1 |
| Bramanti, P | 1 |
| Cuzzocrea, S | 7 |
| Douma, CE | 1 |
| de Waart, DR | 1 |
| Zemel, D | 1 |
| Imholz, AL | 1 |
| Koomen, GC | 1 |
| Struijk, DG | 1 |
| Krediet, RT | 1 |
| Yang, CW | 1 |
| Hwang, TL | 1 |
| Wu, CH | 1 |
| Lai, PC | 1 |
| Huang, JY | 1 |
| Yu, CC | 1 |
| Shyr, MH | 1 |
| Huang, CC | 1 |
| Filippelli, A | 1 |
| Zingarelli, B | 3 |
| Falciani, M | 1 |
| Caputi, AP | 6 |
| Rossi, F | 1 |
| Bories, PN | 1 |
| Campillo, B | 1 |
| Azaou, L | 1 |
| Scherman, E | 1 |
| Garcia-Tsao, G | 1 |
| Angulo, P | 1 |
| Garcia, JC | 1 |
| Groszmann, RJ | 1 |
| Cadelina, GW | 1 |
| Costantino, G | 4 |
| Strand, OA | 1 |
| Leone, AM | 1 |
| Giercksky, KE | 1 |
| Skovlund, E | 1 |
| Kirkebøen, KA | 1 |
| Cockrell, A | 1 |
| Laroux, FS | 1 |
| Jourd'heuil, D | 1 |
| Kawachi, S | 1 |
| Gray, L | 1 |
| Van der Heyde, H | 1 |
| Grisham, MB | 1 |
| de Sarro, G | 1 |
| Laurà, R | 1 |
| Ciriaco, E | 1 |
| de Sarro, A | 1 |
| Sottile, A | 1 |
| Teti, D | 1 |
| Dugo, L | 1 |
| Barbera, A | 1 |
| Centorrino, T | 1 |
| Ciccolo, A | 1 |
| Fonti, MT | 1 |
1 trial available for nitrates and Primary Peritonitis
| Article | Year |
|---|---|
N(G)-monomethyl-L-arginine improves survival in a pig model of abdominal sepsis.
Topics: Animals; Bacteremia; Critical Care; Disease Models, Animal; Enzyme Inhibitors; Hemodynamics; Nitrate | 1998 |
22 other studies available for nitrates and Primary Peritonitis
| Article | Year |
|---|---|
Preclinical evaluation of the urokinase receptor-derived peptide UPARANT as an anti-inflammatory drug.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Cyclooxygenase 2; Dexamethasone; Edema; Male; Mice; | 2017 |
Characterization of the anti-inflammatory properties of NCX 429, a dual-acting compound releasing nitric oxide and naproxen.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Disease Models, Animal; Drug Evaluat | 2015 |
The Nitric Oxide Synthase Inhibitor NG-Nitro-L-Arginine Methyl Ester Diminishes the Immunomodulatory Effects of Parental Arginine in Rats with Subacute Peritonitis.
Topics: Adjuvants, Immunologic; Animals; Arginine; Body Weight; Cytokines; Immunophenotyping; Male; NG-Nitro | 2016 |
Effects of combined levosimendan and vasopressin on pulmonary function in porcine septic shock.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Drug Therapy, Combination; Female; Hemodynamics; HMG- | 2012 |
Appropriate dose of parenteral arginine enhances immunity of peripheral blood cells and splenocytes in rats with subacute peritonitis.
Topics: Animals; Arginine; Chronic Disease; Concanavalin A; Cytokines; Deficiency Diseases; Dietary Suppleme | 2012 |
The dose-dependent immunoregulatory effects of the nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester in rats with sub-acute peritonitis.
Topics: Acute Disease; Animals; Arginine; Body Weight; Cell Proliferation; Cytokines; Dose-Response Relation | 2012 |
Toll-like receptors expression and NF-κB activation in peritoneal leukocytes in morphine-mediated impairment of zymosan-induced peritonitis in swiss mice.
Topics: Analgesics, Opioid; Animals; Cell Line; Flow Cytometry; Keratinocytes; Leukocytes; Male; Mice; Morph | 2012 |
Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Animals; Biomarkers; Blood Pressure; Blood Urea Nit | 2004 |
Effects of glutamine supplementation on splenocyte cytokine mRNA expression in rats with septic peritonitis.
Topics: Animal Feed; Animals; Cytokines; Glutamine; Lymphocytes; Male; Nitrates; Nitrites; Peritonitis; Rats | 2005 |
Assessment of inflammatory mediators in patients with generalized peritonitis.
Topics: Adult; Aged; Aged, 80 and over; Cytokines; Endotoxins; Female; Group IV Phospholipases A2; Humans; I | 1999 |
Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
Topics: Animals; Gene Deletion; Interleukin-10; Interleukin-1beta; Kidney; Lipid Peroxidation; Liver; Mice; | 2008 |
Nitrate in stable CAPD patients and during peritonitis.
Topics: Acute Disease; Adult; Aged; Biological Transport; Creatinine; Dialysis Solutions; Female; Humans; Ma | 1995 |
Peritoneal nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Topics: Acinetobacter Infections; Adult; Aged; Biomarkers; Dialysis Solutions; Female; Humans; Kidney Failur | 1996 |
Role of nitric oxide in a nonseptic shock model induced by zymosan in the rat.
Topics: Acute Disease; Animals; Ascitic Fluid; Blood Pressure; Cardiovascular Diseases; Enzyme Inhibitors; M | 1997 |
Long-lasting NO overproduction in cirrhotic patients with spontaneous bacterial peritonitis.
Topics: Adult; Aged; Aged, 80 and over; Ascitic Fluid; Bacterial Infections; C-Reactive Protein; Female; Hum | 1997 |
The diagnostic and predictive value of ascites nitric oxide levels in patients with spontaneous bacterial peritonitis.
Topics: Ascites; Bacterial Infections; Creatinine; Female; Humans; Male; Middle Aged; Nitrates; Nitric Oxide | 1998 |
Protective effect of melatonin in a non-septic shock model induced by zymosan in the rat.
Topics: Acute Disease; Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Chemotaxis, Leukocyte; | 1998 |
Role of inducible nitric oxide synthase in leukocyte extravasation in vivo.
Topics: Acute Disease; Animals; Ascitic Fluid; Blotting, Western; Cell Movement; Disease Models, Animal; Enz | 1999 |
Role of interleukin-6 in a non-septic shock model induced by zymosan.
Topics: Animals; Antibodies, Monoclonal; Ascites; Ascitic Fluid; DNA Damage; Energy Metabolism; Injections, | 1999 |
Protective effect of N-acetylcysteine on multiple organ failure induced by zymosan in the rat.
Topics: Acetylcysteine; Animals; Body Weight; Disease Models, Animal; Drug Evaluation, Preclinical; Free Rad | 1999 |
Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat.
Topics: Animals; Benzamides; Body Weight; Disease Models, Animal; Drug Evaluation, Preclinical; Male; Multip | 1999 |
Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan.
Topics: Animals; Enzyme Inhibitors; Exudates and Transudates; Guanidines; Lipid Peroxidation; Liver; Lung; M | 2001 |